Method to Alter Chinese Hamster Ovary Cell Line Stability

Technology

Chinese hamster ovary (CHO) cells are the primary choice for producing recombinant therapeutic proteins due to their adaptability, growth traits, and their ability to perform complex post-translational modifications. However, a major challenge with CHO cells is their instability. Over time, they can mutate, potentially altering their productivity or the quality of the proteins they produce. This instability poses a significant concern for the consistency, safety, and economic efficiency of biopharmaceutical manufacturing. This invention introduces a novel method to enhance the stability of CHO cell lines using advanced genetic engineering techniques. The method involves transfecting CHO cells with vectors that carry corrected copies of genes critical for DNA damage repair. This enhances the production and activity of DNA repair proteins, thereby improving DNA repair efficiency and ensuring genomic stability. Additionally, the technology includes steps for screening and selecting host cells that exhibit superior capabilities in repairing double-strand breaks, which leads to reliable, cost-effective therapeutic protein production. Integrating essential vectors into the genome facilitates the stable production of recombinant proteins, thus enhancing productivity and stability under DNA-damaging conditions. This invention marks a major advance in biomanufacturing, introducing a new method for enhancing CHO cell stability for diverse protein production applications.

Benefits

  • Enhances cell line and genome stability
  • Provides a cost-effective and time-efficient solution for enhanced therapeutic protein production
  • Reduces development time
  • Features advanced repair capabilities

Applications

  • Cell line development companies
  • Biopharmaceutical companies